Search

everythinglearnresearchcommunity

for

Search:↓

Insulin-sensitizing drugs like metformin can help with ovulation, weight loss, and lower testosterone in some women with PCOS.

The medications 5α-reductase inhibitors and spironolactone are generally safe for breast cancer patients on endocrine therapies and do not significantly increase breast cancer risk.

Testosterone therapy can help improve mood, sexual function, and bone health in women with low androgen levels, but more research is needed to establish safe and effective guidelines.

Selective Androgen Receptor Modulators (SARMs) are drugs that can control the effects of androgens in different tissues, potentially having fewer side effects and promising for treating various conditions.

The document suggests various treatments for PCOS, including medication for menstrual issues, insulin resistance, and excess hair, as well as fertility treatments, while highlighting the need for personalized care and lifestyle changes.

Trilostane effectively treated hair loss in Alaskan Malamutes with no adverse effects.

The document concludes that treatments for female hair loss and excessive hair growth are temporary and not well-studied.

The conclusion is that young women with excessive hair growth should be quickly tested for hormonal issues and treated to improve their social well-being.

AGA treatments like minoxidil and LLLLT are safe and effective for gender minority patients.

Using 5-alpha-reductase inhibitors, drugs for prostate issues and hair loss, may lead to eye abnormalities in men.

The conclusion is that PCOS is a common cause of hirsutism in young obese women, and early treatment is important to reduce the risk of metabolic syndrome.

Finasteride effectively treats hair loss and enlarged prostate in men, with mild side effects.

A balanced diet and healthy lifestyle help manage PCOS symptoms.

Benign ovarian tumors can cause excess male hormones and related conditions in postmenopausal women.

Insulin resistance may contribute to hair loss in people with androgenic alopecia.

PCOS is a hormonal disorder causing symptoms like irregular periods and acne, and increases the risk of diabetes and heart disease.

Flutamide caused damage to male rat reproductive organs and may affect fertility.

Treatments for hair loss vary, but cell-based options may be the future.

The report recommends personalized treatment for women's sexual dysfunctions and more research on effective therapies.

Finasteride effectively treats BPH, but needs more trials to understand potential.

Male hormones, particularly DHT, are linked to male pattern hair loss, and treatments like finasteride can help, but they don't work for postmenopausal women's hair loss, which may have different causes.

Obesity worsens PCOS symptoms, and PCOS may lead to more weight gain; managing both requires a holistic approach that includes mental health.

Testosterone supplements can increase muscle mass and strength in older men with low levels, but long-term effects and risks need more research.

Obesity increases the risk of developing polycystic ovary syndrome, and weight loss can improve the condition.

PPAR agonists show promise for skin conditions but need more research before being a main treatment.

Metformin has limited effectiveness for improving PCOS symptoms and lacks clear benefits, needing more research to confirm its efficacy.

Flutamide reduces hair growth better but has more side effects.

Hidradenitis suppurativa improves with antiandrogen therapy.

Androgens significantly affect female hair loss, and hormonal treatments may help.

Patients with acanthosis nigricans often have insulin resistance and signs of increased male hormones, but treatment targeting these male hormones is generally ineffective.